Cargando…
The Effects of SGLT2 Inhibitors on Liver Cirrhosis Patients with Refractory Ascites: A Literature Review
Decompensated liver cirrhosis is often complicated by refractory ascites, and intractable ascites are a predictor of poor prognosis in patients with liver cirrhosis. The treatment of ascites in patients with cirrhosis is based on the use of aldosterone blockers and loop diuretics, and occasionally v...
Autores principales: | Miyamoto, Yasunori, Honda, Akira, Yokose, Seiji, Nagata, Mariko, Miyamoto, Jiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056954/ https://www.ncbi.nlm.nih.gov/pubmed/36983252 http://dx.doi.org/10.3390/jcm12062253 |
Ejemplares similares
-
Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor
por: Miyamoto, Yasunori, et al.
Publicado: (2021) -
Ascites, refractory ascites and hyponatremia in cirrhosis
por: Fortune, Brett, et al.
Publicado: (2017) -
SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites
por: Gao, Yuan, et al.
Publicado: (2021) -
Ascites in Cirrhosis of the Liver
Publicado: (1905) -
Current management of refractory ascites in patients with cirrhosis
por: Zhao, Ruihong, et al.
Publicado: (2017)